Origin and evolution of dengue virus type 2 causing outbreaks in Kenya: Evidence of circulation of two cosmopolitan genotype lineages.
Kenya
dengue virus 2
evolution
origin
phylogenetics
Journal
Virus evolution
ISSN: 2057-1577
Titre abrégé: Virus Evol
Pays: England
ID NLM: 101664675
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
entrez:
12
6
2020
pubmed:
12
6
2020
medline:
12
6
2020
Statut:
epublish
Résumé
Dengue fever (DF) is an arboviral disease caused by dengue virus serotypes 1-4 (DENV 1-4). Globally, DF incidence and disease burden have increased in the recent past. Initially implicated in a 1982 outbreak, DENV-2 recently reemerged in Kenya causing outbreaks between 2011 and 2014 and more recently 2017-8. The origin and the evolutionary patterns that may explain the epidemiological expansion and increasing impact of DENV-2 in Kenya remain poorly understood. Using whole-genome sequencing, samples collected during the 2011-4 and 2017-8 dengue outbreaks were analyzed. Additional DENV-2 genomes were downloaded and pooled together with the fourteen genomes generated in this study. Bioinformatic methods were used to analyze phylogenetic relationships and evolutionary patterns of DENV-2 causing outbreaks in Kenya. The findings from this study have shown the first evidence of circulation of two different Cosmopolitan genotype lineages of DENV-2; Cosmopolitan-I (C-I) and Cosmopolitan-II (C-II), in Kenya. Our results put the origin location of C-I lineage in India in 2011, and C-II lineage in Burkina Faso between 1979 and 2013. C-I lineage was the most isolated during recent outbreaks, thus showing the contribution of this newly emerged strain to the increased DENV epidemics in the region. Our findings, backed by evidence of recent local epidemics that have been associated with C-I in Kenya and C-II in Burkina Faso, add to the growing evidence of expanding circulation and the impact of multiple strains of DENV in the region as well as globally. Thus, continued surveillance efforts on DENV activity and its evolutionary trends in the region, would contribute toward effective control and the current vaccine development efforts.
Identifiants
pubmed: 32523778
doi: 10.1093/ve/veaa026
pii: veaa026
pmc: PMC7266482
doi:
Types de publication
Journal Article
Langues
eng
Pagination
veaa026Informations de copyright
© The Author(s) 2020. Published by Oxford University Press.
Références
East Afr Med J. 2001 Dec;78(12):655-61
pubmed: 12199448
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
PeerJ. 2016 Aug 24;4:e2326
pubmed: 27635316
Genome Announc. 2018 Apr 12;6(15):
pubmed: 29650565
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Virol J. 2011 Jul 27;8:371
pubmed: 21794131
Vaccine. 2015 Nov 27;33 Suppl 4:D24-31
pubmed: 26122583
Bioinformatics. 2006 Dec 15;22(24):3096-8
pubmed: 17110367
Syst Biol. 2012 May;61(3):539-42
pubmed: 22357727
Microbiol Resour Announc. 2019 Jan 24;8(4):
pubmed: 30701251
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Lancet Infect Dis. 2009 Nov;9(11):678-87
pubmed: 19850226
J Comput Biol. 2013 Oct;20(10):714-37
pubmed: 24093227
Clin Infect Dis. 2007 Jun 1;44(11):1401-7
pubmed: 17479933
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
BMC Infect Dis. 2016 Aug 11;16(1):406
pubmed: 27514512
East Afr Med J. 1982 Dec;59(12):781-4
pubmed: 7184757
Infect Genet Evol. 2009 Jul;9(4):523-40
pubmed: 19460319
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Lancet. 1982 Jul 24;2(8291):208-9
pubmed: 6123900
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Virol J. 2016 Nov 4;13(1):182
pubmed: 27814732
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Am J Trop Med Hyg. 2019 May;100(5):1249-1257
pubmed: 30860010
Mol Biol Evol. 2003 Oct;20(10):1650-8
pubmed: 12832629
Lancet. 1999 Mar 27;353(9158):1100-1
pubmed: 10199378
PLoS One. 2018 Jun 7;13(6):e0198556
pubmed: 29879159
Clin Epidemiol. 2013 Aug 20;5:299-309
pubmed: 23990732
Clin Microbiol Rev. 1998 Jul;11(3):480-96
pubmed: 9665979
Gaoxiong Yi Xue Ke Xue Za Zhi. 1994 Dec;10 Suppl:S15-8
pubmed: 7844844
Virus Res. 2016 Feb 2;213:23-31
pubmed: 26569594
Sci Rep. 2017 Apr 05;7:45505
pubmed: 28378782
Am J Trop Med Hyg. 2007 Mar;76(3):405-7
pubmed: 17360859
PLoS Negl Trop Dis. 2016 Oct 26;10(10):e0004981
pubmed: 27783626
PLoS Negl Trop Dis. 2015 Apr 29;9(4):e0003733
pubmed: 25923210
J Gen Virol. 2008 Nov;89(Pt 11):2754-2760
pubmed: 18931072
Trans R Soc Trop Med Hyg. 1948 Jul;42(1):83-8
pubmed: 18878518
Bull World Health Organ. 1970;43(4):539-52
pubmed: 5313066
Virology. 2002 Jun 20;298(1):63-72
pubmed: 12093174
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Genome Announc. 2017 Apr 27;5(17):
pubmed: 28450505
J Gen Virol. 2006 Apr;87(Pt 4):885-93
pubmed: 16528038
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
J Virol. 2010 Jul;84(13):6497-504
pubmed: 20410280
Heliyon. 2019 Apr 10;5(4):e01455
pubmed: 31008393
PLoS One. 2015 Sep 28;10(9):e0138900
pubmed: 26414178